Verastem | VSTM - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.21M 131K 2025-09
AstraZeneca USD 1.55B 206K 2025-12
Curis USD 59K 934K 2023-09
Cytokinetics USD 122.26M 145K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Verastem USD 4K 1000 2024-09